Status:
COMPLETED
Observation of Initial Procalcitonin and the Clinical Course of Patients With Acute Respiratory Tract Infections
Lead Sponsor:
Hannover Medical School
Conditions:
Respiratory Tract Infections
Eligibility:
All Genders
18+ years
Brief Summary
Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.
Detailed Description
Primary endpoint: * initial Procalcitonin values of patients with Acute Respiratory Tract Infections Secondary endpoints: * correlation of initial Procalcitonin values to classify Acute Respiratory...
Eligibility Criteria
Inclusion
- written informed consent
- all types of respiratory tract infection according to investigator´s diagnosis
Exclusion
- pretreatment with antibiotics in the past 2 weeks
- portal hypertension
- Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks
- Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease)
- Peritoneal dialysis
- Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid
- Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis
Key Trial Info
Start Date :
December 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
702 Patients enrolled
Trial Details
Trial ID
NCT00827060
Start Date
December 1 2006
End Date
September 1 2007
Last Update
January 28 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical School Hannover, Department Pneumology
Hanover, Germany, 30625